1-4 of 4
Sarah R. Klein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses

Xia Bu, Vikram R. Juneja, Carol G. Reynolds, Kathleen M. Mahoney, Melissa T. Bu, Kathleen A. McGuire, Seth Maleri, Ping Hua, Baogong Zhu, Sarah R. Klein, Edward A. Greenfield, Philippe Armand, Jerome Ritz, Arlene H. Sharpe, Gordon J. Freeman
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (12): 1465–1475.
https://doi.org/10.1158/2326-6066.CIR-21-0493
Published: 01 December 2021
View articletitled, Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses
Open the PDF for Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses in another window
Journal Articles

Abstract B84: Preclinical analysis of combinatorial glioblastoma therapy with the prodrug-mediated gene therapy vector AdV-TK and immune checkpoint inhibition

Maria Carmela Speranza, Franz Ricklefs, Carmela Passaro, Sarah R. Klein, Kazue Kasai, Johanna Kaufmann, Hiroshi Nakashima, Bronisz Agnieszka, Estuardo Aguilar-Cordova, Brian W. Guzik, Gordon J. Freeman, David A. Reardon, Patrick Wen, E. Antonio Chiocca, Sean E. Lawler
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): B84.
https://doi.org/10.1158/2326-6074.TUMIMM16-B84
Published: 28 February 2017
View articletitled, Abstract B84: Preclinical analysis of combinatorial glioblastoma therapy with the prodrug-mediated gene therapy vector AdV-TK and immune checkpoint inhibition
Journal Articles

Abstract A075: Preclinical analysis of combinatorial glioblastoma therapy with the prodrug-mediated gene therapy vector AdV-TK and immune checkpoint inhibition in GBM therapy

Maria Carmela Speranza, Kazue Kasai, Franz Ricklefs, Sarah R. Klein, Carmela Passaro, Hiroshi Nakashima, Johanna Kaufmann, Agnieszka Bronisz, Estuardo Aguilar-Cordova, Brian W. Guzik, Gordon J. Freeman, David A. Reardon, Patrick Wen, E. Antonio Chiocca, Sean E. Lawler
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): A075.
https://doi.org/10.1158/2326-6066.IMM2016-A075
Published: 31 October 2016
View articletitled, Abstract A075: Preclinical analysis of combinatorial glioblastoma therapy with the prodrug-mediated gene therapy vector AdV-TK and immune checkpoint inhibition in GBM therapy
Journal Articles

Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model

David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein, Keith L. Ligon, Scott J. Rodig, Shakti H. Ramkissoon, Kristen L. Jones, Amy Saur Conway, Xiaoyun Liao, Jun Zhou, Patrick Y. Wen, Annick D. Van Den Abbeele, F. Stephen Hodi, Lei Qin, Nancy E. Kohl, Arlene H. Sharpe, Glenn Dranoff, Gordon J. Freeman
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (2): 124–135.
https://doi.org/10.1158/2326-6066.CIR-15-0151
Published: 01 February 2016
View articletitled, Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
Open the PDF for Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model in another window
Includes: Supplementary data